EVGN
Evogene Ltd

3,746
Mkt Cap
$8.37M
Volume
110,053.00
52W High
$2.42
52W Low
$0.91
PE Ratio
-1.96
EVGN Fundamentals
Price
$0.976
Prev Close
$0.96
Open
$0.97
50D MA
$1.06
Beta
0.82
Avg. Volume
27,606.75
EPS (Annual)
-$2.89
P/B
7.33
Rev/Employee
$72,743.59
$14.13
Loading...
Loading...

About

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
117

Frequently Asked Questions

What is Market Cap of Evogene Ltd?
What is the 52-week high for Evogene Ltd?
What is the 52-week low for Evogene Ltd?
What is Evogene Ltd stock price today?
What was Evogene Ltd stock price yesterday?
What is the PE ratio of Evogene Ltd?
What is the Price-to-Book ratio of Evogene Ltd?
What is the 50-day moving average of Evogene Ltd?
How many employees does Evogene Ltd have?

Latest EVGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.